Bernhard Saalfrank

Bernhard Saalfrank is an experienced finance professional currently serving as Vice President of Finance for Europe at Krystal Biotech, Inc. since June 2022. Previous roles include Head of Finance for Europe at Atara Biotherapeutics from April 2018 to April 2021, CFO at Orphan Technologies Ltd. from October 2016 to March 2018, and VP Finance/CFO at Neovii Pharmaceuticals AG from October 2014 to March 2018. Additionally, Bernhard held the position of Head of Finance for Europe, Middle East, and Africa at Onyx Pharmaceuticals between June 2013 and September 2014, and served as Associate Director of Affiliate Finance and CFO at Biogen Idec Switzerland AG from May 2009 to May 2013. Bernhard began a finance career at Amgen from 2000 to 2009 as a Controller. Bernhard holds a degree from Texas A&M University.